ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q1 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $20,000 | -81.0% | 13,512 | -72.0% | 0.00% | – |
| Q4 2021 | $105,000 | -45.9% | 48,245 | -11.5% | 0.00% | – |
| Q3 2021 | $194,000 | -71.4% | 54,530 | -53.9% | 0.00% | -100.0% |
| Q2 2021 | $679,000 | +165.2% | 118,337 | +139.7% | 0.00% | – |
| Q1 2021 | $256,000 | +232.5% | 49,368 | +44.6% | 0.00% | – |
| Q4 2019 | $77,000 | -47.6% | 34,140 | -51.1% | 0.00% | – |
| Q3 2019 | $147,000 | – | 69,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |